Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Aug 02 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-02-2024-8

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 02, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Nelarabine Injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial)".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases